Age-related macular degeneration (AMD) is a progressive blinding disease affecting the central retina and is a leading cause of vision loss globally. It is estimated to affect close to 9% of the worldwide population, which is expected to total 288 million patients by 20401. Unsurprisingly, numerous epidemiological studies have explored the underlying causes and associations with AMD onset and disease progression.
Premium subscriber content
Sign in if you have a Digital or Print + Digital subscription. Don’t have one yet? Digital subscribers get full access to this article from $40/year +GST.
- Premium exclusive content
- Full digital magazine archive
- Early access to new articles
